Dr. Reddy's Laboratories Limited
RDY
$14.51
$0.090.62%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.14% | 14.14% | 13.21% | 10.91% | 8.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.14% | 14.14% | 13.21% | 10.91% | 8.45% |
| Cost of Revenue | 16.98% | 14.37% | 10.41% | 8.70% | 7.14% |
| Gross Profit | 10.48% | 13.98% | 15.22% | 12.48% | 9.38% |
| SG&A Expenses | 15.45% | 19.49% | 18.87% | 17.29% | 14.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -53.93% | -18.99% | -0.95% | -16.74% | -3.87% |
| Total Operating Expenses | 15.46% | 16.47% | 15.03% | 13.27% | 10.89% |
| Operating Income | 5.38% | 6.64% | 7.34% | 3.54% | 1.01% |
| Income Before Tax | 4.11% | 4.57% | 3.88% | 6.15% | 10.45% |
| Income Tax Expenses | 15.08% | 18.32% | 6.80% | 9.28% | -3.80% |
| Earnings from Continuing Operations | 0.82% | 0.57% | 2.93% | 5.15% | 15.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.29% | -0.68% | 1.48% | 3.48% | 15.58% |
| EBIT | 5.38% | 6.64% | 7.34% | 3.54% | 1.01% |
| EBITDA | 7.49% | 7.75% | 7.91% | 4.24% | 2.67% |
| EPS Basic | -0.34% | -0.80% | 1.32% | 3.25% | 15.15% |
| Normalized Basic EPS | 5.68% | 5.34% | 5.33% | 4.88% | 5.81% |
| EPS Diluted | -0.31% | -0.77% | 1.36% | 3.33% | 15.37% |
| Normalized Diluted EPS | 5.72% | 5.36% | 5.32% | 4.88% | 5.96% |
| Average Basic Shares Outstanding | 0.05% | 0.12% | 0.16% | 0.21% | 0.37% |
| Average Diluted Shares Outstanding | 0.01% | 0.08% | 0.13% | 0.17% | 0.19% |
| Dividend Per Share | -4.05% | -4.05% | -1.03% | -1.03% | -1.03% |
| Payout Ratio | -0.01% | 0.00% | -0.03% | -0.04% | 0.11% |